OVERVIEW
The market for drug screening is expected to reach USD 10.22 billion by 2024, growing over the forecast period at a CAGR of 9.6%. Factors such as increased consumption of drugs and alcohol, enforcement of strict laws requiring drug and alcohol testing, and regulatory approvals and new product & service launches are driving market growth.
TABLE OF CONTENT
1 Global Drug Screening MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Drug Screening Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Drug Screening Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Drug Screening Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Drug Screening Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Drug Screening Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Drug Screening Market – By Product & Services (Market Size – & million/billion)
8.1 Drug Screening Products
8.2 Drug Screening Services
9 Global Drug Screening Market – By Sample Type
9.1 Urine
9.2 Breath
9.3 Oral Fluid
9.4 Hair
9.5 Other
10 Global Drug Screening Market – By End-User
10.1 Criminal Justice Systems and Law Enforcement Agencies
10.2 Drug Treatment Centers
10.3 Pain Management Centers
10.4 Schools and Colleges
10.5 Hospitals
10.6 Drug testing laboratories
11 Global Drug Screening Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Drug Screening Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Drug Screening Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Alere
13.3 Thermo Fisher Scientific
13.4 Lifeloc
13.5 Omega Laboratories
13.6 Premier Biotech
13.7 Drägerwerk
13.8 Quest Diagnostics
13.9 Labcorp
13.10 Alfa Scientific Designs
13.11 Orasure
13.12 Company 11 & more
14 Global Drug Screening Market – Appendix
14.1 Sources
14.2 Abbreviations